Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Clinical trial NCT03824561 · COMPLETED

Trial details

NCT number: NCT03824561
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Ulcerative Colitis

Start date: 2019-02-01
Primary completion: 2025-02-12
Enrollment: 1110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.